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In 2013, the network supported 282 addict patients. 121
patients including 24 women are infected with HIV or
HCV and 109 have hepatitis C. All have a substitution
of Buprenorphine or Methadone treatment. 110 / 121
patients have a general practitioner and 101 / 121 have
a regular pharmacist. (figure1).
25 patients are cured of hepatitis C out of 47 who received
treatment and 14 patients are cured spontaneously without
treatment. Among 121 patients, 16 have already been hospi-
talized in psychiatry. 45 patients have a psychiatric co-mor-
bidity and 40 are treated for this disease. (figure 2).
Very few patients have less than 200 CD4. (figure 3).
Most patients were followed up since 2008. (figure 4).
Conclusion
Addict patients take subscribe to a course of complex care,
and often long term. They are often supported in a com-
plementary manner by the city and the hospital. Their
immune status for seropositive patients of HIV are often
above 200 CD4. They often have an associated psychiatric
comorbidity for which they receive treatment. When the
treatment with Interferon is go on, only ½ is cured. Today,
they most often have non-treated hepatitis C.
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